Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

OSL:BAKKA - Oslo Bors ASA - FO0000000179 - Common Stock - Currency: NOK

616  -1.5 (-0.24%)

Fundamental Rating

6

BAKKA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 60 industry peers in the Food Products industry. BAKKA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BAKKA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BAKKA had positive earnings in the past year.
In the past year BAKKA had a positive cash flow from operations.
BAKKA had positive earnings in each of the past 5 years.
Each year in the past 5 years BAKKA had a positive operating cash flow.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B -2B -3B

1.2 Ratios

BAKKA has a Return On Assets (3.30%) which is in line with its industry peers.
BAKKA's Return On Equity of 5.34% is in line compared to the rest of the industry. BAKKA outperforms 42.11% of its industry peers.
With a decent Return On Invested Capital value of 6.91%, BAKKA is doing good in the industry, outperforming 68.42% of the companies in the same industry.
BAKKA had an Average Return On Invested Capital over the past 3 years of 6.07%. This is in line with the industry average of 6.86%.
The 3 year average ROIC (6.07%) for BAKKA is below the current ROIC(6.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.3%
ROE 5.34%
ROIC 6.91%
ROA(3y)6.64%
ROA(5y)5.92%
ROE(3y)10.68%
ROE(5y)9.42%
ROIC(3y)6.07%
ROIC(5y)6.02%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

The Profit Margin of BAKKA (7.52%) is better than 77.19% of its industry peers.
In the last couple of years the Profit Margin of BAKKA has declined.
With an excellent Operating Margin value of 18.43%, BAKKA belongs to the best of the industry, outperforming 87.72% of the companies in the same industry.
In the last couple of years the Operating Margin of BAKKA has declined.
BAKKA's Gross Margin of 68.19% is amongst the best of the industry. BAKKA outperforms 96.49% of its industry peers.
In the last couple of years the Gross Margin of BAKKA has remained more or less at the same level.
Industry RankSector Rank
OM 18.43%
PM (TTM) 7.52%
GM 68.19%
OM growth 3Y16.87%
OM growth 5Y-8.76%
PM growth 3Y10.38%
PM growth 5Y-15.04%
GM growth 3Y5.67%
GM growth 5Y-1.16%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAKKA is destroying value.
The number of shares outstanding for BAKKA remains at a similar level compared to 1 year ago.
BAKKA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BAKKA has a worse debt to assets ratio.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

BAKKA has an Altman-Z score of 3.63. This indicates that BAKKA is financially healthy and has little risk of bankruptcy at the moment.
BAKKA's Altman-Z score of 3.63 is amongst the best of the industry. BAKKA outperforms 85.96% of its industry peers.
The Debt to FCF ratio of BAKKA is 3.38, which is a good value as it means it would take BAKKA, 3.38 years of fcf income to pay off all of its debts.
BAKKA has a better Debt to FCF ratio (3.38) than 80.70% of its industry peers.
BAKKA has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
BAKKA has a better Debt to Equity ratio (0.36) than 80.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 3.38
Altman-Z 3.63
ROIC/WACC0.82
WACC8.42%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

2.3 Liquidity

A Current Ratio of 6.03 indicates that BAKKA has no problem at all paying its short term obligations.
BAKKA has a better Current ratio (6.03) than 98.25% of its industry peers.
BAKKA has a Quick Ratio of 2.04. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
BAKKA has a better Quick ratio (2.04) than 87.72% of its industry peers.
Industry RankSector Rank
Current Ratio 6.03
Quick Ratio 2.04
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.73% over the past year.
BAKKA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.08% yearly.
BAKKA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.71%.
BAKKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.58% yearly.
EPS 1Y (TTM)1.73%
EPS 3Y41.32%
EPS 5Y1.08%
EPS Q2Q%-49.83%
Revenue 1Y (TTM)0.71%
Revenue growth 3Y15.36%
Revenue growth 5Y17.58%
Sales Q2Q%-6.6%

3.2 Future

Based on estimates for the next years, BAKKA will show a very strong growth in Earnings Per Share. The EPS will grow by 23.66% on average per year.
Based on estimates for the next years, BAKKA will show a quite strong growth in Revenue. The Revenue will grow by 12.72% on average per year.
EPS Next Y5.14%
EPS Next 2Y20.48%
EPS Next 3Y23.66%
EPS Next 5YN/A
Revenue Next Year5.93%
Revenue Next 2Y11.27%
Revenue Next 3Y12.72%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.23, the valuation of BAKKA can be described as rather expensive.
BAKKA's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.47, BAKKA is valued a bit cheaper.
With a Price/Forward Earnings ratio of 15.46, BAKKA is valued correctly.
BAKKA's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 92.74. BAKKA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 22.23
Fwd PE 15.46
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAKKA indicates a slightly more expensive valuation: BAKKA is more expensive than 66.67% of the companies listed in the same industry.
BAKKA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 20.29
EV/EBITDA 12.58
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BAKKA may justify a higher PE ratio.
A more expensive valuation may be justified as BAKKA's earnings are expected to grow with 23.66% in the coming years.
PEG (NY)4.33
PEG (5Y)20.5
EPS Next 2Y20.48%
EPS Next 3Y23.66%

2

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.09%.
BAKKA's Dividend Yield is comparable with the industry average which is at 3.24.
Compared to an average S&P500 Dividend Yield of 2.28, BAKKA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.09%

5.2 History

The dividend of BAKKA decreases each year by -0.95%.
Dividend Growth(5Y)-0.95%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BAKKA pays out 90.53% of its income as dividend. This is not a sustainable payout ratio.
DP90.53%
EPS Next 2Y20.48%
EPS Next 3Y23.66%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (2/5/2025, 2:43:57 PM)

616

-1.5 (-0.24%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-17 2025-02-17/amc
Inst Owners62.89%
Inst Owner ChangeN/A
Ins Owners16.05%
Ins Owner ChangeN/A
Market Cap36.53B
Analysts80
Price Target755.92 (22.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.09%
Yearly Dividend10
Dividend Growth(5Y)-0.95%
DP90.53%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.36%
Min EPS beat(2)-51.09%
Max EPS beat(2)-23.64%
EPS beat(4)2
Avg EPS beat(4)-16.01%
Min EPS beat(4)-51.09%
Max EPS beat(4)8.77%
EPS beat(8)3
Avg EPS beat(8)-15.09%
EPS beat(12)3
Avg EPS beat(12)-15.78%
EPS beat(16)4
Avg EPS beat(16)-23.62%
Revenue beat(2)0
Avg Revenue beat(2)-10.46%
Min Revenue beat(2)-12.34%
Max Revenue beat(2)-8.57%
Revenue beat(4)1
Avg Revenue beat(4)-7.18%
Min Revenue beat(4)-12.34%
Max Revenue beat(4)2.47%
Revenue beat(8)3
Avg Revenue beat(8)-0.75%
Revenue beat(12)5
Avg Revenue beat(12)-1.33%
Revenue beat(16)6
Avg Revenue beat(16)-2.33%
PT rev (1m)-1.16%
PT rev (3m)-1.91%
EPS NQ rev (1m)-1.73%
EPS NQ rev (3m)-8.84%
EPS NY rev (1m)-9.55%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)2.69%
Revenue NQ rev (3m)-8.74%
Revenue NY rev (1m)-2.1%
Revenue NY rev (3m)-2.1%
Valuation
Industry RankSector Rank
PE 22.23
Fwd PE 15.46
P/S 3.07
P/FCF 20.29
P/OCF 10.69
P/B 2.18
P/tB 3.79
EV/EBITDA 12.58
EPS(TTM)27.71
EY4.5%
EPS(NY)39.84
Fwd EY6.47%
FCF(TTM)30.35
FCFY4.93%
OCF(TTM)57.61
OCFY9.35%
SpS200.59
BVpS282.33
TBVpS162.72
PEG (NY)4.33
PEG (5Y)20.5
Profitability
Industry RankSector Rank
ROA 3.3%
ROE 5.34%
ROCE 8.49%
ROIC 6.91%
ROICexc 7.28%
ROICexgc 10.25%
OM 18.43%
PM (TTM) 7.52%
GM 68.19%
FCFM 15.13%
ROA(3y)6.64%
ROA(5y)5.92%
ROE(3y)10.68%
ROE(5y)9.42%
ROIC(3y)6.07%
ROIC(5y)6.02%
ROICexc(3y)6.29%
ROICexc(5y)6.39%
ROICexgc(3y)8.95%
ROICexgc(5y)9.69%
ROCE(3y)7.46%
ROCE(5y)7.4%
ROICexcg growth 3Y14.6%
ROICexcg growth 5Y-11.25%
ROICexc growth 3Y20.69%
ROICexc growth 5Y-15.33%
OM growth 3Y16.87%
OM growth 5Y-8.76%
PM growth 3Y10.38%
PM growth 5Y-15.04%
GM growth 3Y5.67%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 3.38
Debt/EBITDA 1.82
Cap/Depr 147.25%
Cap/Sales 13.59%
Interest Coverage 250
Cash Conversion 103.86%
Profit Quality 201.31%
Current Ratio 6.03
Quick Ratio 2.04
Altman-Z 3.63
F-Score7
WACC8.42%
ROIC/WACC0.82
Cap/Depr(3y)202.35%
Cap/Depr(5y)452.66%
Cap/Sales(3y)17.43%
Cap/Sales(5y)34.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.73%
EPS 3Y41.32%
EPS 5Y1.08%
EPS Q2Q%-49.83%
EPS Next Y5.14%
EPS Next 2Y20.48%
EPS Next 3Y23.66%
EPS Next 5YN/A
Revenue 1Y (TTM)0.71%
Revenue growth 3Y15.36%
Revenue growth 5Y17.58%
Sales Q2Q%-6.6%
Revenue Next Year5.93%
Revenue Next 2Y11.27%
Revenue Next 3Y12.72%
Revenue Next 5YN/A
EBIT growth 1Y0.57%
EBIT growth 3Y34.81%
EBIT growth 5Y7.28%
EBIT Next Year58.89%
EBIT Next 3Y36.36%
EBIT Next 5YN/A
FCF growth 1Y7544.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.6%
OCF growth 3Y29.22%
OCF growth 5Y2.3%